Technology Assisted Motivational Interviewing
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Nov 27, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help people quit smoking using a digital coach called a chatbot. The trial aims to improve motivation to quit smoking and to overcome social challenges that can make it hard to stop. Participants will use this chatbot to receive personalized support, helpful information in multiple languages about quitting smoking, and a customized plan that addresses their specific needs and obstacles.
To join the trial, you need to be at least 18 years old, smoke at least one cigarette a day, and have a device like a phone or tablet to access the program. You should also be moderately comfortable using English and be able to commit to participating for six months. However, if you are already in a smoking cessation program or using medication to help quit, you won't be eligible. This study is not yet recruiting, but it offers a unique opportunity for those looking to quit smoking with the support of modern technology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • A current Primary Care Provider patient
- • Age 18 or older
- • Smoke at least 1 cigarette per day for the past 7 consecutive days (and at least 100 lifetime)
- • Have a digital device (phone, laptop, tablet)
- • Moderately proficient in English
- • Able to participate for 6-month trial
- Exclusion Criteria:
- • Current participation in a smoking cessation program
- • Current use of Nicotine Replacement Therapy or smoking cessation pharmacotherapy
- • Cognitive impairment that would preclude informed consent
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
San Francisco, California, United States
Patients applied
Trial Officials
Jason Satterfield, PhD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported